JPS61239890A - Stabilized peroxidase solution - Google Patents

Stabilized peroxidase solution

Info

Publication number
JPS61239890A
JPS61239890A JP7984985A JP7984985A JPS61239890A JP S61239890 A JPS61239890 A JP S61239890A JP 7984985 A JP7984985 A JP 7984985A JP 7984985 A JP7984985 A JP 7984985A JP S61239890 A JPS61239890 A JP S61239890A
Authority
JP
Japan
Prior art keywords
peroxidase
solution
acid
stabilized
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7984985A
Other languages
Japanese (ja)
Other versions
JPS6324677B2 (en
Inventor
Zenjiro Kanda
神田 善治郎
Kazuo Kojima
和夫 小島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical and Biological Laboratories Co Ltd
Original Assignee
Medical and Biological Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical and Biological Laboratories Co Ltd filed Critical Medical and Biological Laboratories Co Ltd
Priority to JP7984985A priority Critical patent/JPS61239890A/en
Publication of JPS61239890A publication Critical patent/JPS61239890A/en
Publication of JPS6324677B2 publication Critical patent/JPS6324677B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:A stabilized peroxidase solution providing a reagent which is preservable for a long period and has fixed qualities, obtained by adding serum protein and one or more of specific carboxlic acids to a solution of (peroxidase) bonded substance. CONSTITUTION:1l aqueous solution of (peroxidase) bonded substance extracted from a horseradish is blended with serum protein of serum albumin and 10mg-1g parahydroxyphenylcarboxylic acid [e.g., (parahydroxyphenyl)acetic acid and/or propionic acid] shown by the formula (R is CH2, CH2-CH2, CH2-CH2- CH2, CH3-CH-CH2, CH=CH, CH=CH-CH2, or CH3-C=CH).

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、免疫化学的測定法の一つである酵素免疫測定
法(以下r、EIAJと言う。)や免疫組織化学的染色
法等に用いられるペルオキシダーゼ又はその結合体の長
期保存可能な溶液に関するものである。
[Detailed Description of the Invention] [Industrial Application Field] The present invention is applicable to enzyme immunoassay (hereinafter referred to as EIAJ), which is one of the immunochemical measurement methods, immunohistochemical staining method, etc. The present invention relates to a long-term storage solution of peroxidase or its conjugate to be used.

[従来の技術] 生体に作用する種々の蛋白、ホルモン等を高感度で測定
するための免疫化学的測定法あるいは生体の任意の組織
を視覚化する免疫組織化学的染色法は近年、臨床検査の
分野等で重要性を増している。免疫化学的測定法の一つ
としては、EIAが広く用いられている。この測定法は
、抗原又は抗体を酵素で標識し、これと基質とを反応さ
せ、酵素によって合成された化合物の量で目的とする蛋
白、又はホルモン等を定量する方法である。
[Prior Art] In recent years, immunochemical assay methods for measuring various proteins, hormones, etc. that act on living organisms with high sensitivity, and immunohistochemical staining methods for visualizing arbitrary tissues of living organisms, have become popular in clinical examinations. It is gaining importance in various fields. EIA is widely used as one of the immunochemical measurement methods. This measurement method is a method in which an antigen or antibody is labeled with an enzyme, this is reacted with a substrate, and the target protein, hormone, etc. is quantified based on the amount of the compound synthesized by the enzyme.

一方、免疫組織化学的染色法は、特定の組織に存在する
蛋白等に特異的に結合した抗体に他の抗体を利用して酵
素を標識し、基質との反応により発色させて、組織にお
けるその成分の局在を証明する方法である。
On the other hand, in immunohistochemical staining, antibodies that specifically bind to proteins present in a particular tissue are labeled with an enzyme using another antibody, and the color is developed by reaction with a substrate. This is a method to prove the localization of components.

これらの方法に用いられる代表的な酵素に過酸化水素に
より基質を酸化する、西洋わさび等から抽出したペルオ
キシダーゼがある。この酵素は分子量が比較的小さく、
反応が早いため、短時間で感度の高い測定・染色が可能
となる。
A typical enzyme used in these methods is peroxidase extracted from horseradish or the like, which oxidizes a substrate with hydrogen peroxide. This enzyme has a relatively small molecular weight;
Because the reaction is fast, highly sensitive measurements and staining are possible in a short period of time.

[発明が解決しようとする問題点] しかし、ペルオキシダーゼは他の成分と結合し1   
  ていると否とにかかわりなく希釈溶液状態では極め
て貯蔵安定性が悪く、試薬製品としての流通に困難性を
有し、その有用性に比較して利用度が低い状況にある。
[Problems to be solved by the invention] However, peroxidase binds to other components and
Regardless of whether it is in diluted form or not, it has extremely poor storage stability in a diluted solution state, making it difficult to distribute as a reagent product, and its usage is low compared to its usefulness.

この対策として動物血清を、ペルオキシダーゼ溶液中に
添加し安定化させようとしているが、血清中に存在する
ヘミン結合蛋白との間のヘミン相互作用により不活性化
を生じ、やはり長期保存には適さないものであった。
As a countermeasure to this problem, efforts have been made to stabilize animal serum by adding it to a peroxidase solution, but this results in inactivation due to hemin interaction with the hemin-binding protein present in serum, making it unsuitable for long-term storage. It was something.

そこで本発明は貯蔵安定性の極めて高いペルオキシダー
ゼ溶液を提供することを目的として完成されたものであ
る。
Therefore, the present invention was completed with the aim of providing a peroxidase solution with extremely high storage stability.

[問題点を解決するための手段] 本発明は、上記問題点の解決手段として次のような構成
を採用するものである。
[Means for Solving the Problems] The present invention employs the following configuration as a means for solving the above problems.

即ち本発明は、 ペルオキシダーゼ又はペルオキシダーゼ結合体の溶液中
に、 血清蛋白と、 パラハイドロキシフェニルカルボン酸の1種又は2種以
上と、 が含有されてなることを特徴とする安定化ペルオキシダ
ーゼ溶液を要旨とする。
That is, the gist of the present invention is a stabilized peroxidase solution, characterized in that the solution of peroxidase or peroxidase conjugate contains: serum protein and one or more parahydroxyphenyl carboxylic acids. do.

ここでペルオキシダーゼとは、過酸化水素を水。Here, peroxidase refers to hydrogen peroxide in water.

素置容体として種々の物質の酸化を触媒する酵素を言い
、西洋わさび、牛乳、酵母、白血球、赤血球等から抽出
されるものが挙げられ、特に西洋わさびのペルオキシダ
ーゼが本発明の安定化の効果を顕著に示す。
Enzymes that catalyze the oxidation of various substances are used as preservatives, and include those extracted from horseradish, milk, yeast, white blood cells, red blood cells, etc. In particular, horseradish peroxidase exhibits the stabilizing effect of the present invention. Show noticeably.

又、酵素は抽出されたままの単体ばかりか、予め抗体等
に結合しておいたペルオキシダーゼ結合体でも同様に用
いることができる。例えばウサギやヤギの族ペルオキシ
ダーゼとペルオキシダーゼとの抗原抗体反応による結合
体等である。
Furthermore, the enzyme can be used not only as a single enzyme as extracted, but also as a peroxidase conjugate that has been previously bound to an antibody or the like. For example, it is a conjugate of rabbit or goat peroxidase and peroxidase resulting from an antigen-antibody reaction.

血清蛋白とは各種動物の血清アルブミン、血清グロブリ
ン等の血清に含まれる蛋白を言う。
Serum proteins refer to proteins contained in serum such as serum albumin and serum globulin of various animals.

パラハイドロキシフェニルカルボン酸とは、例えば式 ここでRは2価の炭化水素基であり、例えばCH2、C
H2−CH2、CH2−CH2−CH2、CHa−CH
−CH2、CH−CH,CH−CH−CH2、CHs−
C−CH等が挙げられる。
Parahydroxyphenylcarboxylic acid has the formula, for example, where R is a divalent hydrocarbon group, such as CH2, C
H2-CH2, CH2-CH2-CH2, CHa-CH
-CH2, CH-CH, CH-CH-CH2, CHs-
Examples include C-CH.

上記式で表わされる化合物の内でも、バラハイドロキシ
フェニル酢酸、3−パラハイドロキシフェニルカルボン
酸及び2−バラハイドロキシフ工二ルブロビオン酸が、
ペルオキシダーゼの安定性上、より好ましい化合物であ
る。
Among the compounds represented by the above formula, barahydroxyphenylacetic acid, 3-parahydroxyphenylcarboxylic acid and 2-barahydroxyphenylcarboxylic acid,
This is a more preferred compound in terms of peroxidase stability.

上記各成分は通常、媒質に分散されているが、普通、媒
質は水が用いられ、必要に応じて緩衝用の塩類等が溶解
される。
The above-mentioned components are usually dispersed in a medium, and water is usually used as the medium, and buffering salts and the like are dissolved as necessary.

パラハイドロキシフェニルカルボン酸の濃度は溶液1立
中101(]〜1gが安定性が高く、この内でも500
+ac+〜10が特に高安定性である。
The concentration of parahydroxyphenylcarboxylic acid is highly stable at a concentration of 101 (] to 1 g per 1 solution, and within this range, 500
+ac+ to 10 is particularly stable.

[作用] 本発明の作用は未だ明らかにされていないが、おそらく
次のようではないかと想像される。
[Function] Although the function of the present invention has not yet been clarified, it is likely to be as follows.

前記したごとくペルオキシダーゼは血清蛋白とはヘミン
相互作用を生じ、不活性化の原因となる。
As mentioned above, peroxidase interacts with hemin with serum proteins, causing inactivation.

しかしパラハイドロキシフェニルカルボン酸が存在する
ことにより、このものが血清蛋白のヘミン相互作用を生
ずる部位に作用すると考えられる。
However, due to the presence of parahydroxyphenylcarboxylic acid, it is thought that this acts on the site of hemin interaction in serum proteins.

その結果、ペルオキシダーゼと血清蛋白とのヘミン相互
作用が妨害され血清蛋白による安定効果が全て引き出さ
れるものと考えられる。
As a result, it is thought that the hemin interaction between peroxidase and serum proteins is disrupted, and all of the stabilizing effects of serum proteins are brought out.

[発明の効果] 本発明は上述したごとく、ペルオキシダーゼ又はペルオ
キシダーゼ結合体と血清蛋白とに加えてパラハイドロキ
シフェニルカルボン酸を添加している。
[Effects of the Invention] As described above, in the present invention, parahydroxyphenylcarboxylic acid is added in addition to peroxidase or peroxidase conjugate and serum protein.

そのため、ペルオキシダーゼ又はペルオキシダーゼ結合
体が極めて安定となり長期保存が可能となり、医療・生
物学等の分野の各種測定用として安定した一定品質の試
薬を提供でき、正確な診断等に貢献できるものである。
Therefore, peroxidase or peroxidase conjugate is extremely stable and can be stored for a long period of time, making it possible to provide reagents of stable and constant quality for various measurements in the fields of medicine, biology, etc., and contributing to accurate diagnosis.

[実施例] 0、2mo/m lのペルオキシダーゼ(西洋わさびよ
り抽出)濃度に相当するペルオキシダーゼ標1   識
抗プタイ″リン0原液を・10a 、、l(Dつ2血清
アルブミン(コーン フラクション■)及び0.25g
/iの「チメロサール」(Th1lerO3a1)(丸
石製薬:防腐剤)及び、0.1510立/立の塩化ナト
リウムを含有する0、01moA/Ωのリン酸ナトリウ
ム緩衝液(pH−8,0)にて200倍、400倍、8
00倍、1600倍に稀釈し、41度のペルオキシダー
ゼ標識抗ブタインスリン溶液をmg〜4した。このペル
オキシダーゼ標識抗ブタインスリン溶液に各々0.01
0 /41゜0.1o /n、1g/nのバラハイドロ
キシフェニル10ピオン酸く以下HPPAで表わす)又
はバラハイドロキシフェニル酢m<a下HPAAで表わ
す)を添加した後、0.5mg〜01/立のリン酸2ナ
トリウム溶液でI)Hを7.0にmg〜9した。これら
のペルオキシダーゼ標識抗ブタインスリン溶液を、4〜
8℃又は37℃で貯蔵した。ざらにHPPA又はHPA
Aの安定化効果をみるため、両試薬を添加しないものを
同様に4〜8℃又は37℃で貯蔵し、さらにペルオキシ
ダーゼ活性の対照として凍結(−20℃)で貯蔵した。
[Example] A peroxidase label corresponding to a concentration of peroxidase (extracted from horseradish) of 0.2 mo/ml was prepared using a peroxidase label 1 10a, 10a, 1 (D), 2 serum albumin (cohn fraction) and 0.25g
/i "Thimerosal" (Th1lerO3a1) (Maruishi Pharmaceutical: preservative) and 0.01 moA/Ω sodium phosphate buffer (pH -8.0) containing 0.1510 mA/m sodium chloride. 200x, 400x, 8
The peroxidase-labeled anti-porcine insulin solution was diluted 00 times and 1600 times to 41 mg. 0.01 each to this peroxidase-labeled anti-porcine insulin solution.
After adding 0/41°0.1o/n, 1 g/n of rose hydroxyphenyl 10 pionic acid (hereinafter expressed as HPPA) or rose hydroxyphenyl acetic acid m<a (hereinafter expressed as HPAA), 0.5 mg~01/n I)H was adjusted to 7.0 mg to 9 mg with di-sodium phosphate solution. These peroxidase-labeled anti-porcine insulin solutions were
Stored at 8°C or 37°C. Zarani HPPA or HPA
To examine the stabilizing effect of A, samples without both reagents were similarly stored at 4-8°C or 37°C, and further stored frozen (-20°C) as a control for peroxidase activity.

特定時間経過した後に以下の2つの方法でペルオキシダ
ーゼ標識抗ブタインスリン溶液の活性を測定した。
After a specific period of time had elapsed, the activity of the peroxidase-labeled anti-porcine insulin solution was measured using the following two methods.

(1)ペルオキシダーゼ活性安定化認識試験貯蔵したペ
ルオキシダーゼ標識抗ブタインスリン溶液を、pH−5
,5のクエン酸−リンWi2ナトリウム0.1lo1/
Aに7nmoi/iのH2021及び160IIIIl
O1/立のグルコースを加えた溶液(以下基質溶解用I
衝溶液という)でmg〜倍に稀釈し、そのmg〜0μ立
を、基質溶解用緩衝液で溶解した0、 6mm0 A、
/fLのオルトフェニレンジアミン溶液0.mg〜1l
に添加し、室温にて5分間インキュベートした後、2N
−Hz So a 100μ立の添加により反応を停止
させその吸光度(A帽)を測定した。その結果を第1表
及び第2表に示す。第1表は4℃貯蔵のもの、第2表は
37℃貯蔵のものを示す。ここで数値はHPPA10/
立添加したものの活性に対する比活性を計算したもので
ある。又、その内用1図に稀釈倍率1600で4℃貯蔵
のもの、第2図に同稀釈倍率で37℃貯蔵のものの比活
性の経時変化のグラフを示す。
(1) Peroxidase activity stabilization recognition test The stored peroxidase-labeled anti-porcine insulin solution was
,5 citric acid-phosphorus Wi disodium 0.1lo1/
7nmoi/i of H2021 and 160IIIl in A
A solution to which 01/d of glucose was added (hereinafter referred to as I for substrate dissolution)
0.6 mm 0 A,
/fL of orthophenylenediamine solution 0. mg~1l
After incubating for 5 minutes at room temperature, 2N
The reaction was stopped by adding 100 μl of −Hz Soa, and its absorbance (A) was measured. The results are shown in Tables 1 and 2. Table 1 shows those stored at 4°C, and Table 2 shows those stored at 37°C. Here the numbers are HPPA10/
The specific activity is calculated with respect to the activity of the added product. In addition, Fig. 1 shows graphs of changes in specific activity over time for samples stored at 4°C at a dilution rate of 1600, and Fig. 2 for samples stored at 37°C at the same dilution rate.

このようにHPPA又はHPAAを添加しないものは1
週間でほぼ活性を失ってしまうのに対し本実施例のもの
はそれ以後も長期にわたって活性を保持している。
In this way, those without adding HPPA or HPAA are 1
In contrast, the activity of this example is maintained for a long period of time, whereas the activity is almost lost within a week.

(2)分析試験による活性安定化確認試験杭ブタインス
リンモルモットIoGを35μQ/翔立の濃度で感作し
たマイクロプレート(ダイナチック社 イムロン■)に
、100μLl/l iのブタインスリン溶液を100
μ立1時間空温で反応させ洗浄した後、貯蔵したペルオ
キシダーゼ標識波ブタインスリン溶液を各100μ文添
加し1時間室温で反応させた。洗浄した後基質溶解用m
g〜衝液で溶解した3mn+ofL/uのオルトフェニ
レンジアミン溶液100μ文を添加し、室温にて30分
間反応させた後、2N−HzSOa溶液100μ立の添
加により反応を停止させ、その吸光度(A胡2)を測定
した。
(2) Activity stabilization confirmation test by analytical test Pig insulin 100μL/l i of porcine insulin solution was added to a microplate (Dynatic Imron ■) sensitized with guinea pig IoG at a concentration of 35μQ/Shortate.
After reacting at room temperature for 1 hour and washing, 100 μl each of the stored peroxidase-labeled porcine insulin solution was added and reacted for 1 hour at room temperature. For substrate dissolution after washing
After adding 100μ of a solution of 3m+ofL/u of orthophenylenediamine dissolved in a buffer solution and reacting for 30 minutes at room temperature, the reaction was stopped by adding 100μ of a 2N-Hz SOa solution, and its absorbance (Ahu2 ) was measured.

、I HPPA又はHPAAの安定化効果を測定するために凍
結(−20℃)保存したものと比較したその結果を第3
表及び第4表に示す。第3表は4℃貯蔵のもの、第4表
は37℃貯蔵のものを示す。
In order to measure the stabilizing effect of HPPA or HPAA, the results were compared with those stored frozen (-20°C).
It is shown in Table and Table 4. Table 3 shows those stored at 4°C, and Table 4 shows those stored at 37°C.

、 又、第3図〜第10図に凍結貯蔵のものとの比活性
に換算したグラフを示す。第3図〜第6図は4℃貯蔵の
ものを表わし、第3図は200倍稀釈、第4図は400
倍稀釈、第5図は800倍稀釈、第6図は1600倍稀
釈のものを表わす。又第7図〜第10図は37℃貯蔵の
ものを表わし、第7図は200倍稀釈、第8図は400
倍稀釈、第9図は800倍稀釈、第10図は1600倍
稀釈のものを表わす。
In addition, graphs of specific activities compared to those stored frozen are shown in FIGS. 3 to 10. Figures 3 to 6 represent samples stored at 4°C, with Figure 3 diluted 200 times and Figure 4 diluted 400 times.
Figure 5 shows the 800-fold dilution, and Figure 6 shows the 1600-fold dilution. In addition, Figures 7 to 10 show samples stored at 37°C, with Figure 7 showing 200-fold dilution and Figure 8 showing 400-fold dilution.
FIG. 9 shows the 800-fold dilution, and FIG. 10 shows the 1600-fold dilution.

このようにHPPA又はHPAAを添加しないものは1
0日はどで、はとんど活性を示さなくなるのに対して、
本実施例のものは、それ以後も分析試験に用いることが
できり特に4℃貯蔵のものは、60日後も、はとんどか
わらず、精密な分析に用いることができる。
In this way, those without adding HPPA or HPAA are 1
On day 0, it hardly shows any activity, whereas
The samples of this example can be used for analytical tests even after that, and especially those stored at 4°C can be used for precise analysis even after 60 days.

この他ペルオキシダーゼ自体を用いて同様な試験を行っ
たが、はぼ同様に、極めて安定性が高くなるという結果
を得た。
A similar test was conducted using peroxidase itself, and the results showed that the peroxidase had extremely high stability, similar to the case with Habo.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は4℃における貯蔵安定化確認試験の内、160
0倍稀釈のものの比活性経口変化を示すグラフ、第2図
は37℃における同様のグラフ、第3図乃至第6図は4
℃における分析試験による活性安定化確認試験の経日変
化を示すグラフであって、第3図は200倍稀釈のグラ
フ、第4図は400倍稀釈のグラフ、第5図は800倍
稀釈のグラフ、第6図は1600倍稀釈のグラフを示し
、第7図乃至第10図は37℃における分析試験による
活性安定化確認試験の経日変化を示すグラフであって、
第7図は200倍稀釈のグラフ、第8図は400倍稀釈
のグラフ、第9図は800倍稀釈のグラフ、第10図は
1600倍稀釈のグラフを示す。
Figure 1 shows 160 of the storage stability confirmation tests at 4°C.
Graph showing oral changes in specific activity for 0x dilution; Figure 2 is a similar graph at 37°C; Figures 3 to 6 are 4
3 is a graph showing a 200-fold dilution, FIG. 4 is a 400-fold dilution, and FIG. 5 is an 800-fold dilution. , FIG. 6 shows a graph of a 1600-fold dilution, and FIGS. 7 to 10 are graphs showing changes over time in an activity stabilization confirmation test by an analytical test at 37°C,
FIG. 7 shows a graph for 200 times dilution, FIG. 8 shows a graph for 400 times dilution, FIG. 9 shows a graph for 800 times dilution, and FIG. 10 shows a graph for 1600 times dilution.

Claims (1)

【特許請求の範囲】 1 ペルオキシダーゼ又はペルオキシダーゼ結合体の溶
液中に、 血清蛋白と、 パラハイドロキシフェニルカルボン酸の1種又は2種以
上と、 が含有されてなることを特徴とする安定化ペルオキシダ
ーゼ溶液。 2 ペルオキシダーゼ又はペルオキシダーゼ結合体の反
応原料のペルオキシダーゼが西洋わさびから抽出された
ものである特許請求の範囲第1項記載の安定化ペルオキ
シダーゼ溶液。 3 ペルオキシダーゼ結合体が、ペルオキシダーゼと該
ペルオキシダーゼを抗原とする抗体との結合体である特
許請求の範囲第1項又は第2項記載の安定化ペルオキシ
ダーゼ溶液。 4 パラハイドロキシフェニルカルボン酸が溶液1l中
に10mg〜1g含有される特許請求の範囲第1項乃至
第3項のいずれか記載の安定化ペルオキシダーゼ溶液。 5 パラハイドロキシフェニルカルボン酸がパラハイド
ロキシフェニル酢酸及び/又はパラハイドロキシフェニ
ルプロピオン酸である特許請求の範囲第1項乃至第4項
のいずれか記載の安定化ペルオキシダーゼ溶液。
[Scope of Claims] 1. A stabilized peroxidase solution comprising: a serum protein; and one or more parahydroxyphenyl carboxylic acids in a solution of peroxidase or peroxidase conjugate. 2. The stabilized peroxidase solution according to claim 1, wherein peroxidase as a reaction raw material for peroxidase or peroxidase conjugate is extracted from horseradish. 3. The stabilized peroxidase solution according to claim 1 or 2, wherein the peroxidase conjugate is a conjugate of peroxidase and an antibody using the peroxidase as an antigen. 4. The stabilized peroxidase solution according to any one of claims 1 to 3, wherein 1 liter of solution contains 10 mg to 1 g of parahydroxyphenylcarboxylic acid. 5. The stabilized peroxidase solution according to any one of claims 1 to 4, wherein the parahydroxyphenylcarboxylic acid is parahydroxyphenylacetic acid and/or parahydroxyphenylpropionic acid.
JP7984985A 1985-04-15 1985-04-15 Stabilized peroxidase solution Granted JPS61239890A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7984985A JPS61239890A (en) 1985-04-15 1985-04-15 Stabilized peroxidase solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7984985A JPS61239890A (en) 1985-04-15 1985-04-15 Stabilized peroxidase solution

Publications (2)

Publication Number Publication Date
JPS61239890A true JPS61239890A (en) 1986-10-25
JPS6324677B2 JPS6324677B2 (en) 1988-05-21

Family

ID=13701643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7984985A Granted JPS61239890A (en) 1985-04-15 1985-04-15 Stabilized peroxidase solution

Country Status (1)

Country Link
JP (1) JPS61239890A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516672A (en) * 1988-04-26 1996-05-14 Konica Corporation Stabilized peroxidase compositions and antibody compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516672A (en) * 1988-04-26 1996-05-14 Konica Corporation Stabilized peroxidase compositions and antibody compositions

Also Published As

Publication number Publication date
JPS6324677B2 (en) 1988-05-21

Similar Documents

Publication Publication Date Title
Burch et al. Improved method for measurement of delta-aminolevulinic acid dehydratase activity of human erythrocytes
JP3184894B2 (en) Haloperoxidase acid optimal chemiluminescence analysis system
JPH0926423A (en) Synthetic calibrator for use in immunoassay containing body under test formed as composite for inactive carrier moleculeor partial alignment thereof
JPS6122254A (en) Bioluminescence coupling determination method
CN105164532A (en) Methods and reagents for determining isomeric analytes
JPH0322946B2 (en)
EP0844484B1 (en) Method for producing a stable troponin preparation and the use thereof as a calibrator/control in immunoassays
JP2001515581A (en) Stabilized standards and test substances
JPH0242982A (en) Stable peroxidase composition and stable antibody composition
Thiele et al. Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption
JPH11316228A (en) Immediately usable prothrombin time reagent based on recombinant tissue factor
KR900002840B1 (en) Stabilized enryme conjugate composition
JPS61239890A (en) Stabilized peroxidase solution
US5610076A (en) Method for detecting hemoglobin advanced glycosylation endproducts
EP0045122A1 (en) Stabilization of creatine kinase (ck) and its application as a reference standard
JPWO2016021678A1 (en) Protein stabilizer and protein stabilization method
JPH0419561A (en) Blocking agent for immunoassay
Bouchard et al. Glutamyl Substrate-Induced Exposure of a Free Cysteine Residue in the Vitamin K-Dependent γ-Glutamyl Carboxylase Is Critical for Vitamin K Epoxidation
JP4178632B2 (en) Methods and reagents for avoiding interference effects
Pokrovsky et al. Plasma pharmacokinetics and tissue distribution of L-lysine α-oxidase from Trichoderma cf. aureoviride RIFAI VKM F-4268D in mice
US9551723B2 (en) Liquid reagent of thyroid hormone-immobilized carrier and use thereof
US5217890A (en) Stabilized composition containing creatine kinase and protein having blocked sulfhydryl groups
JP2000352565A (en) Method for stabilizing analyte in urine specimen and conservation agent for it
JP2654932B2 (en) C-reactive protein measurement reagent
JPS6178385A (en) Stable peroxidase composition

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term